Professor | 胥洋 | 数字化转型顾问

	Upload Avatar (500 x 500)
Name	胥洋
Contact Information	xuyang_pucri@bjmu.edu.cn
Language ability	中文, 英文
Province	北京

Upload Avatar (500 x 500)

Name

胥洋

Contact Information

xuyang_pucri@bjmu.edu.cn

Language ability

中文, 英文

Province

北京

University/Lab Affiliation and Title	北京大学
Faculty	Pharmaceutical Sciences
Academic Background & Achievements	2018 医学博士: 北京大学 2015 理学硕士: 北京大学 2013 理学/经济学学士: 北京大学
Work Experience	2023.08至今 - 北京大学 - 药事管理与临床药学系 - 副研究员 2021.06-2023.07 - 北京大学 - 临床研究所 - 副研究员 2019.02-2021.02 - 瑞典卡罗琳斯卡学院 - 临床流行病与生物统计学系 - 博士后 2018.09-2019.01 - 北京大学 - 健康医疗大数据国家研究院 - 助理研究员
Awards	2023-2024: 第60届欧洲肾脏病年会最佳摘要

University/Lab Affiliation and Title

北京大学

Faculty

Pharmaceutical Sciences

Academic Background & Achievements

2018 医学博士: 北京大学
2015 理学硕士: 北京大学
2013 理学/经济学学士: 北京大学

Work Experience

2023.08至今 - 北京大学 - 药事管理与临床药学系 - 副研究员
2021.06-2023.07 - 北京大学 - 临床研究所 - 副研究员
2019.02-2021.02 - 瑞典卡罗琳斯卡学院 - 临床流行病与生物统计学系 - 博士后
2018.09-2019.01 - 北京大学 - 健康医疗大数据国家研究院 - 助理研究员

Awards

2023-2024: 第60届欧洲肾脏病年会最佳摘要

Areas of Focus	药械的真实世界安全性有效性评价
Publications	Poor recognition and undertreatment of anemia in patients with chronic kidney disease managed in primary care, 胥洋, Evans M, Mazhar F, 等, 2023 Long-term Visit-to-Visit Variability in Hemoglobin A(1c) and Kidney-Related Outcomes in Persons With Diabetes, 胥洋, Dong S, Fu EL, Sjölander A, Grams ME, Selvin E, Carrero JJ, 2023 National incidence and mortality of hospitalized sepsis in China, Weng L#, 胥洋#, Yin P#, Wang Y, Chen Y, Liu W, Li S, Peng JM, Dong R, Hu XY, Jiang W, Wang CY, Gao P, Zhou MG, Du B 和中国重症监护临床试验组, 2023 GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes, 胥洋#, Fu EL#, Clase CM, Mazhar F, Jardine MJ, Carrero JJ, 2022 Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes, 胥洋, Fu EL, Trevisan M, Jernberg T, Sjölander A, Clase CM, Carrero JJ, 2022 Burden and causes of hospital admissions and readmissions in patients undergoing hemodialysis and peritoneal dialysis: a nationwide study, 胥洋#, Li L#, Evans M, Xu H, Lindholm B, Carrero JJ, 2021 Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease, 胥洋, Evans M, Soro M, Barany P, Carrero JJ, 2021 Factors affecting pre-end-stage kidney disease haemoglobin control and outcomes following dialysis initiation: a nationwide study, 胥洋, Evans M, Barany P, James G, Sjölander A 和 Carrero JJ, 2021 Glycemic Control and the Risk of Acute Kidney Injury in Patients With Type 2 Diabetes and Chronic Kidney Disease: Parallel Population-Based Cohort Studies in U.S. and Swedish Routine Care, 胥洋, Surapaneni A, Alkas J, Evans M, Shin J-I, Selvin E, Chang A, Grams ME, Carrero JJ, 2020 Sulphonylureas monotherapy and risk of hospitalization for heart failure in patients with type 2 diabetes mellitus: A population-based cohort study in China, 胥洋, Wang T, Yang Z, Lin H, Shen P, Zhan S, 2020

Areas of Focus

药械的真实世界安全性有效性评价

Publications

Poor recognition and undertreatment of anemia in patients with chronic kidney disease managed in primary care, 胥洋*, Evans M, Mazhar F, 等, 2023
Long-term Visit-to-Visit Variability in Hemoglobin A(1c) and Kidney-Related Outcomes in Persons With Diabetes, 胥洋*, Dong S, Fu EL, Sjölander A, Grams ME, Selvin E, Carrero JJ, 2023
National incidence and mortality of hospitalized sepsis in China, Weng L#, 胥洋#, Yin P#, Wang Y, Chen Y, Liu W, Li S, Peng JM, Dong R, Hu XY, Jiang W, Wang CY, Gao P, Zhou MG, Du B 和中国重症监护临床试验组, 2023
GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes, 胥洋#*, Fu EL#, Clase CM, Mazhar F, Jardine MJ, Carrero JJ, 2022
Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes, 胥洋, Fu EL, Trevisan M, Jernberg T, Sjölander A, Clase CM, Carrero JJ, 2022
Burden and causes of hospital admissions and readmissions in patients undergoing hemodialysis and peritoneal dialysis: a nationwide study, 胥洋#, Li L#, Evans M, Xu H, Lindholm B, Carrero JJ, 2021
Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease, 胥洋, Evans M, Soro M, Barany P, Carrero JJ, 2021
Factors affecting pre-end-stage kidney disease haemoglobin control and outcomes following dialysis initiation: a nationwide study, 胥洋, Evans M, Barany P, James G, Sjölander A 和 Carrero JJ, 2021
Glycemic Control and the Risk of Acute Kidney Injury in Patients With Type 2 Diabetes and Chronic Kidney Disease: Parallel Population-Based Cohort Studies in U.S. and Swedish Routine Care, 胥洋*, Surapaneni A, Alkas J, Evans M, Shin J-I, Selvin E, Chang A, Grams ME, Carrero JJ, 2020
Sulphonylureas monotherapy and risk of hospitalization for heart failure in patients with type 2 diabetes mellitus: A population-based cohort study in China, 胥洋, Wang T, Yang Z, Lin H, Shen P, Zhan S, 2020

真实世界安全性有效性评价药物医疗器械药物警戒临床结果医疗保健监管科学

程能能 - 复旦大学

朱丹雁 - 浙江大学

View All

Personal Information

Academic Information

Research

联系我们

还未创建账户?

Personal Information

Academic Information

Research

联系我们